Author

C. Heldermon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Franceschini Ghilardi· 1 shared B. Davis· 1 shared B. Law· 1 shared C.-W. Chiang· 1 shared D. Kopinke· 1 shared E. Yaaghubi· 1 shared M. Law· 1 shared M. Wang· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Franceschini Ghilardi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mechanistic Elucidation of the Antitumor Properties of a Novel Death Receptor 5 Activator

M. Wang, M. Law, B. Davis, E. Yaaghubi, A. Franceschini Ghilardi, R. Ferreira, C.-W. Chiang, O. Guryanova, D. Kopinke, C. Heldermon, R. Castellano, B. Law

This study identifies DDAs as compounds that upregulate DR5 in cancer cells, leading to apoptosis and synergy with TRAIL, with selectivity for oncogene-transformed cells.

bioRxiv · Jul 14, 2019 · PreprintCancer Biology